BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33368684)

  • 1. The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy.
    Carino A; Marchianò S; Biagioli M; Scarpelli P; Bordoni M; Di Giorgio C; Roselli R; Fiorucci C; Monti MC; Distrutti E; Zampella A; Fiorucci S
    FASEB J; 2021 Jan; 35(1):e21271. PubMed ID: 33368684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity.
    Sepe V; Renga B; Festa C; Finamore C; Masullo D; Carino A; Cipriani S; Distrutti E; Fiorucci S; Zampella A
    Steroids; 2016 Jan; 105():59-67. PubMed ID: 26607331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice.
    Carino A; Cipriani S; Marchianò S; Biagioli M; Scarpelli P; Zampella A; Monti MC; Fiorucci S
    Sci Rep; 2017 Oct; 7(1):13689. PubMed ID: 29057935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids.
    Renga B; Bucci M; Cipriani S; Carino A; Monti MC; Zampella A; Gargiulo A; d'Emmanuele di Villa Bianca R; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H114-26. PubMed ID: 25934094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
    Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
    PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease.
    Marchianò S; Biagioli M; Bordoni M; Morretta E; Di Giorgio C; Vellecco V; Roselli R; Bellini R; Massa C; Cari L; Urbani G; Ricci P; Monti MC; Giordano A; Brancaleone V; Bucci M; Zampella A; Distrutti E; Cieri E; Cirino G; Fiorucci S
    J Am Heart Assoc; 2023 Dec; 12(23):e031241. PubMed ID: 37996988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation.
    Carino A; Marchianò S; Biagioli M; Fiorucci C; Zampella A; Monti MC; Morretta E; Bordoni M; Di Giorgio C; Roselli R; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 May; 11(5):. PubMed ID: 31117231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of autophagy by an FXR-CREB axis.
    Seok S; Fu T; Choi SE; Li Y; Zhu R; Kumar S; Sun X; Yoon G; Kang Y; Zhong W; Ma J; Kemper B; Kemper JK
    Nature; 2014 Dec; 516(7529):108-11. PubMed ID: 25383523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
    Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.
    Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.
    Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders.
    Fiorucci S; Sepe V; Biagioli M; Fiorillo B; Rapacciuolo P; Distrutti E; Zampella A
    Biochem Pharmacol; 2023 Oct; 216():115776. PubMed ID: 37659739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists.
    De Marino S; Festa C; Sepe V; Zampella A
    Handb Exp Pharmacol; 2019; 256():137-165. PubMed ID: 31201554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
    Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
    J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension.
    Fiorucci S; Distrutti E
    Pharmacol Res; 2016 Sep; 111():749-756. PubMed ID: 27475883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.
    Carino A; Biagioli M; Marchianò S; Fiorucci C; Zampella A; Monti MC; Scarpelli P; Ricci P; Distrutti E; Fiorucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1422-1437. PubMed ID: 31325638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism.
    Stefela A; Kaspar M; Drastik M; Holas O; Hroch M; Smutny T; Skoda J; Hutníková M; Pandey AV; Micuda S; Kudova E; Pavek P
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105702. PubMed ID: 32505574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient-sensing nuclear receptors coordinate autophagy.
    Lee JM; Wagner M; Xiao R; Kim KH; Feng D; Lazar MA; Moore DD
    Nature; 2014 Dec; 516(7529):112-5. PubMed ID: 25383539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH.
    Marchianò S; Biagioli M; Morretta E; Di Giorgio C; Roselli R; Bordoni M; Bellini R; Urbani G; Massa C; Monti MC; Zampella A; Distrutti E; Fiorucci S
    Sci Rep; 2023 Jan; 13(1):1602. PubMed ID: 36709356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.